Russello D, Randazzo G, Favetta A, Cristaldi C, Petino A G, Carnazzo S A, Latteri F
Cattedra Patologia Speciale Chirurgica CO, Università degli Studi di Catania.
Minerva Chir. 1990 Oct 31;45(20):1309-14.
The aim of the study was to evaluate the clinical use of a GABOB by-product in the treatment of exogenous post-concussion syndrome. Thirty-six patients affected by this syndrome were included in the study and divided into two groups. Patients in the first group were treated with the drug, while patients in the second group were not treated. Variations in the average time taken for symptoms to disappear in both groups showed a statistically significant difference in favour of the drug-treated group of patients. Following an analysis of the results it was possible to affirm that the drug had a statistically significant effect in patients affected by medium-severe symptomatology.
该研究的目的是评估一种γ-氨基丁酸（GABOB）副产品在治疗外伤性脑震荡后综合征中的临床应用。36名患有该综合征的患者被纳入研究并分为两组。第一组患者接受该药物治疗，而第二组患者未接受治疗。两组症状消失平均时间的差异显示，药物治疗组患者具有统计学上的显著优势。对结果进行分析后，可以肯定该药物对中重度症状的患者具有统计学上的显著疗效。
